KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Boston Scientific (BSX) Change in Receivables (2020 - 2025)

Historic Change in Receivables for Boston Scientific (BSX) over the last 6 years, with Q4 2025 value amounting to $98.0 million.

  • Boston Scientific's Change in Receivables rose 888.89% to $98.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $269.0 million, marking a year-over-year decrease of 2336.18%. This contributed to the annual value of $269.0 million for FY2025, which is 2336.18% down from last year.
  • Latest data reveals that Boston Scientific reported Change in Receivables of $98.0 million as of Q4 2025, which was up 888.89% from $32.0 million recorded in Q3 2025.
  • Over the past 5 years, Boston Scientific's Change in Receivables peaked at $148.0 million during Q4 2021, and registered a low of -$14.0 million during Q3 2021.
  • For the 5-year period, Boston Scientific's Change in Receivables averaged around $67.8 million, with its median value being $74.5 million (2023).
  • As far as peak fluctuations go, Boston Scientific's Change in Receivables plummeted by 11138.21% in 2021, and later soared by 100000.0% in 2024.
  • Over the past 5 years, Boston Scientific's Change in Receivables (Quarter) stood at $148.0 million in 2021, then tumbled by 70.27% to $44.0 million in 2022, then skyrocketed by 68.18% to $74.0 million in 2023, then grew by 21.62% to $90.0 million in 2024, then rose by 8.89% to $98.0 million in 2025.
  • Its last three reported values are $98.0 million in Q4 2025, $32.0 million for Q3 2025, and $32.0 million during Q2 2025.